UnitedHealth's stock soared 5.03% during intraday trading on Thursday, following a series of bullish analyst actions that boosted investor sentiment.
The surge was primarily driven by BofA Securities upgrading UnitedHealth from Neutral to Buy and raising its price target to $450 from $420. Additionally, Morgan Stanley increased its price target on the stock to $453 from $395 while maintaining an Overweight rating.
These analyst upgrades reflect growing confidence in UnitedHealth's prospects and contributed to the significant price appreciation during the trading session as investors responded to the improved outlook from major financial institutions.